Clinical trial
Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the…
NCT00104013 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00104013 |
|---|---|
| Title | Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type |
| Official title | A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | xaliproden (SR57746A) |
| Enrollment | 1,455 |
| Start date | Nov 1, 2003 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 21, 2005 |
| Last update posted | Aug 21, 2008 |
| Countries | Australia, France, Hong Kong, Italy, Netherlands, Singapore, South Africa, Spain, Taiwan, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: